Back
Day Range
$16.58
$17.36
52-Week Range
$9.24
$19.00
Volume
632,483
50D / 200D Avg
$15.86
/
$14.09
Prev Close
$17.00
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -4.6 | 0.4 |
| P/B | 8.8 | 2.9 |
| ROE % | -121.5 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$32.33
+94.8%
Low: $28.00
High: $37.00
Forward EPS
-$2.57
Est. Revenue
62 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$3.08
$2.72 – $3.32
|
510 M | 2 |
| FY2029 |
$1.96
$1.73 – $2.11
|
420 M | 2 |
| FY2028 |
$0.45
-$2.80 – $7.86
|
300 M | 6 |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 9, 2026 |
Palleiko Benjamin L
CHIEF EXECUTIVE OFFICER
|
sell | 6,693 | $16.08 | $107,633 |
| Mar 6, 2026 |
Palleiko Benjamin L
CHIEF EXECUTIVE OFFICER
|
other | 31,250 | — | — |
| Feb 23, 2026 |
Palleiko Benjamin L
CHIEF EXECUTIVE OFFICER
|
sell | 10,034 | $15.57 | $156,197 |
| Feb 21, 2026 |
Palleiko Benjamin L
CHIEF EXECUTIVE OFFICER
|
other | 46,500 | — | — |
| Feb 18, 2026 |
Palleiko Benjamin L
CHIEF EXECUTIVE OFFICER
|
sell | 1,038 | $15.00 | $15,570 |
| Feb 18, 2026 |
Yea Christopher
CHIEF DEVELOPMENT OFFICER
|
sell | 1,109 | $15.00 | $16,635 |
| Feb 18, 2026 |
Audhya Paul K.
CHIEF MEDICAL OFFICER
|
sell | 1,163 | $15.00 | $17,445 |
| Feb 17, 2026 |
Palleiko Benjamin L
CHIEF EXECUTIVE OFFICER
|
other | 4,838 | — | — |
| Feb 17, 2026 |
Yea Christopher
CHIEF DEVELOPMENT OFFICER
|
other | 3,548 | — | — |
| Feb 17, 2026 |
Audhya Paul K.
CHIEF MEDICAL OFFICER
|
other | 4,838 | — | — |
| Feb 12, 2026 |
Palleiko Benjamin L
CHIEF EXECUTIVE OFFICER
|
sell | 3,354 | $15.70 | $52,658 |
| Feb 11, 2026 |
Palleiko Benjamin L
CHIEF EXECUTIVE OFFICER
|
other | 14,240 | — | — |
| Jan 16, 2026 |
Audhya Paul K.
CHIEF MEDICAL OFFICER
|
grant | 100,000 | — | — |
| Jan 16, 2026 |
Sweeny Nicole
Chief Commercial Officer
|
grant | 100,000 | — | — |
| Jan 16, 2026 |
Arif Bilal
Chief Operations Officer
|
grant | 49,000 | — | — |
| Dec 8, 2025 |
Palleiko Benjamin L
CHIEF EXECUTIVE OFFICER
|
sell | 7,294 | $16.51 | $120,424 |
| Dec 6, 2025 |
Palleiko Benjamin L
CHIEF EXECUTIVE OFFICER
|
other | 31,250 | — | — |
| Nov 24, 2025 |
Palleiko Benjamin L
CHIEF EXECUTIVE OFFICER
|
sell | 10,940 | $13.45 | $147,154 |
| Nov 24, 2025 |
Yea Christopher
CHIEF DEVELOPMENT OFFICER
|
sell | 4,331 | $13.45 | $58,256 |
| Nov 24, 2025 |
Piekos Brian
Chief Financial Officer
|
sell | 4,471 | $13.45 | $60,139 |
Key Takeaways
Debt/Equity of 0.07 — conservative balance sheet
Negative free cash flow of -153.34M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-121.50%
ROIC-138.64%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.07
Current Ratio5.35
Interest Coverage-32.50
Valuation
P/E Ratio
-4.57
P/B Ratio8.80
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -183.44M |
| ROE | -121.50% | ROA | -73.15% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -153.34M |
| ROIC | -138.64% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.07 | Current Ratio | 5.35 |
| Interest Coverage | -32.50 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -4.57 | P/B Ratio | 8.80 |
| P/S Ratio | N/A | PEG Ratio | -0.51 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 839.07M | Enterprise Value | 746.73M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -183.44M | -126.64M | -92.91M | -82.34M | -46.24M |
| EPS (Diluted) | -3.69 | -3.44 | -3.33 | -3.36 | -2.33 |
| Gross Profit | 0.0 | -86.17M | 0.0 | 0.0 | -41.29M |
| Operating Income | -188.00M | -140.45M | -110.87M | -96.61M | -57.92M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 250.77M | 235.40M | 183.20M | 203.88M | 272.01M |
| Total Liabilities | 155.38M | 28.82M | 22.18M | 18.79M | 14.82M |
| Shareholders' Equity | 95.39M | 206.58M | 161.03M | 185.09M | 257.19M |
| Total Debt | 6.31M | 7.32M | 8.23M | 8.19M | 5.91M |
| Cash & Equivalents | 98.64M | 31.79M | 56.24M | 30.73M | 50.59M |
| Current Assets | 241.69M | 225.69M | 172.33M | 193.65M | 264.26M |
| Current Liabilities | 45.17M | 22.81M | 15.03M | 11.58M | 9.77M |